HD-OPM Archive
Topics › GLP-1 drugs (semaglutide, tirzepatide)

Neurologist Perlmutter on what GLP-1 drugs may be doing to the brain

Louis Nervegna · Jun 22, 2026 · ♥ 10 reactions · 2 comments · original Facebook post
GLP-1 drugs (semaglutide, tirzepatide)Brain health & dementia
AI summary & key facts

Louis shares a Yahoo Life article in which neurologist David Perlmutter discusses new brain-scan findings suggesting GLP-1 drugs act beyond appetite, on metabolism, insulin signaling, inflammation and reward pathways. It is a general-audience overview with no specific data in the post.

“What are GLP-1 drugs like Ozempic really doing to the brain? A neurologist explains.”

“New brain scans suggest these blockbuster weight-loss drugs reach far beyond appetite. Board-certified neurologist Dr. David Perlmutter breaks down what is happening inside the brain, who should be cautious, and why the findings should humble us."

Link to article:

YahooWhat are GLP-1 drugs like Ozempic really doing to the brain? A neurologist explainsNew brain scans suggest GLP-1 drugs like Ozempic reach beyond appetite. A neurologist explains what they may do to the brain, and who should be cautious.creators.yahoo.com

#glp1HD #brainHD

When you think about GLP-1 medications, weight loss is probably the first thing that comes to mind.

What I actually find most interesting is what these medications are teaching us about the brain.

GLP-1s appear to influence pathways involved in metabolism, insulin signaling, inflammation, reward processing, and more. It's a reminder that the brain is deeply connected to the rest of the body. I think that's a humbling realization.

The more we learn, the more we discover just how interconnected our biology really is.

I was recently featured in a @Yahoo Life article exploring these findings and what they could mean for the future of brain health: What are GLP-1 drugs like Ozempic really doing to the brain? A neurologist explains (Yahoo)

No photo description available.
← newer: Vitamin K2 slowed coronary calcium only when started early; older: Anti-amyloid antibodies slow early Alzheimer's decline ~30%, →